ICU Medical PE Ratio 2010-2023 | ICUI
Current and historical p/e ratio for ICU Medical (ICUI) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICU Medical PE ratio as of April 22, 2024 is 17.52.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICU Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-23 | 97.76 | 0.00 | |
| 2023-12-31 | 99.74 | $-1.23 | 0.00 |
| 2023-09-30 | 119.01 | $-1.17 | 0.00 |
| 2023-06-30 | 178.19 | $-2.02 | 0.00 |
| 2023-03-31 | 164.96 | $-1.92 | 0.00 |
| 2022-12-31 | 157.48 | $-3.12 | 0.00 |
| 2022-09-30 | 150.60 | $-1.56 | 0.00 |
| 2022-06-30 | 164.39 | $0.42 | 391.40 |
| 2022-03-31 | 222.64 | $2.04 | 109.14 |
| 2021-12-31 | 237.34 | $4.74 | 50.07 |
| 2021-09-30 | 233.38 | $5.04 | 46.31 |
| 2021-06-30 | 205.80 | $4.77 | 43.14 |
| 2021-03-31 | 205.44 | $4.34 | 47.34 |
| 2020-12-31 | 214.49 | $4.03 | 53.22 |
| 2020-09-30 | 182.76 | $3.78 | 48.35 |
| 2020-06-30 | 184.31 | $3.86 | 47.75 |
| 2020-03-31 | 201.77 | $4.04 | 49.94 |
| 2019-12-31 | 187.12 | $4.70 | 39.81 |
| 2019-09-30 | 159.60 | $3.38 | 47.22 |
| 2019-06-30 | 251.91 | $2.15 | 117.17 |
| 2019-03-31 | 239.33 | $2.53 | 94.60 |
| 2018-12-31 | 229.63 | $1.32 | 173.96 |
| 2018-09-30 | 282.75 | $4.01 | 70.51 |
| 2018-06-30 | 293.65 | $4.01 | 73.23 |
| 2018-03-31 | 252.40 | $0.70 | 360.57 |
| 2017-12-31 | 216.00 | $3.33 | 64.86 |
| 2017-09-30 | 185.85 | $1.54 | 120.68 |
| 2017-06-30 | 172.50 | $2.62 | 65.84 |
| 2017-03-31 | 152.70 | $5.47 | 27.92 |
| 2016-12-31 | 147.35 | $3.57 | 41.27 |
| 2016-09-30 | 126.38 | $3.36 | 37.61 |
| 2016-06-30 | 112.75 | $3.25 | 34.69 |
| 2016-03-31 | 104.10 | $3.10 | 33.58 |
| 2015-12-31 | 112.78 | $2.74 | 41.16 |
| 2015-09-30 | 109.50 | $2.87 | 38.15 |
| 2015-06-30 | 95.66 | $2.31 | 41.41 |
| 2015-03-31 | 93.14 | $1.86 | 50.08 |
| 2014-12-31 | 81.90 | $1.69 | 48.46 |
| 2014-09-30 | 64.18 | $2.09 | 30.71 |
| 2014-06-30 | 60.81 | $2.39 | 25.44 |
| 2014-03-31 | 59.88 | $2.49 | 24.05 |
| 2013-12-31 | 63.71 | $2.64 | 24.13 |
| 2013-09-30 | 67.93 | $2.60 | 26.13 |
| 2013-06-30 | 72.06 | $2.70 | 26.69 |
| 2013-03-31 | 58.95 | $2.85 | 20.68 |
| 2012-12-31 | 60.93 | $2.80 | 21.76 |
| 2012-09-30 | 60.48 | $3.24 | 18.67 |
| 2012-06-30 | 53.38 | $3.07 | 17.39 |
| 2012-03-31 | 49.16 | $3.11 | 15.81 |
| 2011-12-31 | 45.00 | $3.15 | 14.29 |
| 2011-09-30 | 36.80 | $2.61 | 14.10 |
| 2011-06-30 | 43.70 | $2.61 | 16.74 |
| 2011-03-31 | 43.78 | $2.50 | 17.51 |
| 2010-12-31 | 36.50 | $2.23 | 16.37 |
| 2010-09-30 | 37.29 | $2.01 | 18.55 |
| 2010-06-30 | 32.17 | $1.78 | 18.07 |
| 2010-03-31 | 34.45 | $1.60 | 21.53 |
| 2009-12-31 | 36.44 | $1.77 | 20.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.348B | $2.259B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
| Stryker (SYK) | United States | $124.672B | 30.91 |
| Medtronic (MDT) | Ireland | $106.983B | 15.15 |
| Boston Scientific (BSX) | United States | $99.792B | 33.18 |
| EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
| ResMed (RMD) | United States | $26.527B | 26.52 |
| Terumo (TRUMY) | Japan | $25.252B | 35.66 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
| Baxter (BAX) | United States | $20.516B | 14.96 |
| Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
| Insulet (PODD) | United States | $11.513B | 60.45 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
| Demant (WILYY) | Denmark | $9.853B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
| BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
| Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
| Haemonetics (HAE) | United States | $4.247B | 21.72 |
| Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
| GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
| Envista Holdings (NVST) | United States | $3.456B | 13.14 |
| QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
| Neogen (NEOG) | United States | $2.552B | 24.54 |
| Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
| TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
| Owens & Minor (OMI) | United States | $1.856B | 17.82 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
| InMode (INMD) | Israel | $1.439B | 7.45 |
| LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
| AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
| Warby Parker (WRBY) | United States | $1.218B | 0.00 |
| AtriCure (ATRC) | United States | $1.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.964B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
| Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
| Evolus (EOLS) | United States | $0.679B | 0.00 |
| Quanterix (QTRX) | United States | $0.623B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Jin Medical (ZJYL) | China | $0.532B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
| PetIQ (PETQ) | United States | $0.486B | 18.14 |
| TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.422B | 25.82 |
| Biote (BTMD) | United States | $0.414B | 3.94 |
| OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
| Surmodics (SRDX) | United States | $0.361B | 39.06 |
| Zynex (ZYXI) | United States | $0.358B | 41.26 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
| Cerus (CERS) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Veru (VERU) | United States | $0.186B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
| Omeros (OMER) | United States | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
| Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.80 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Bright Green (BGXX) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.52 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.001B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |